Marco Taglietti's Net Worth

$2.19 Million

Estimate Recalculated Apr 26, 2024 08:22AM EST

Who is Marco Taglietti?

Marco Taglietti has an estimated net worth of $2.19 Million. This is based on reported shares across multiple companies, which include DELCATH SYSTEMS, INC., SCYNEXIS INC, Aquestive Therapeutics, Inc., Forest Laboratories, LLC, and NephroGenex, Inc..

SEC CIK

Marco Taglietti's CIK is 0001408870

Past Insider Trading and Trends

2015 was Marco Taglietti's most active year for acquiring shares with 19 total transactions. Marco Taglietti's most active month to acquire stocks was the month of November. 2014 was Marco Taglietti's most active year for disposing of shares, totalling 19 transactions. Marco Taglietti's most active month to dispose stocks was the month of June. 2020 saw Marco Taglietti paying a total of $250,000.00 for 986,000 shares, this is the most they've acquired in one year. In 2013 Marco Taglietti cashed out on 12,835 shares for a total of $703,483.48, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

DELCATH SYSTEMS, INC. (DCTH) Snapshot price: $4.64

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
6K
—
—
6K
May 8
Form 4
—
0
—
—
0
Jul 15
Form 4
—
0
—
—
0
Feb 1
Form 4
+1,000.00%
200K
$0.53
$106,783.00
220K
Jul 27 - Jul 28
Form 4
∞
20K
—
—
20K
Jun 10
Form 4
—
0
—
—
0
Dec 11
Form 3
—
0
—
—
0
No matching records found

SCYNEXIS INC (SCYX) Snapshot price: $1.995

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+38.06%
75K
$3.00
$225,000.00
272.07K
Apr 26
Form 4
+79.44%
87.2K
—
—
196.97K
Feb 4
Form 4
—
0
—
—
0
Jan 29
Form 4
+57.42%
40K
$6.25
$250,000.00
109.67K
Dec 21
Form 4
—
0
—
—
0
Jan 31
Form 4
+31.62%
166.67K
$0.90
$150,000.30
693.68K
Dec 12
Form 4
+1.94%
10K
$1.11
$11,100.00
526.01K
Aug 20 - Aug 21
Form 4
+1.98%
10.02K
$1.01
$10,115.15
516.01K
Aug 15
Form 4
+5.20%
25K
$1.63
$40,750.00
506K
Apr 17
Form 4
—
0
—
—
0
Feb 15
Form 4
+5.49%
25K
$0.69
$17,250.00
480K
Jan 10
Form 4
+5.81%
25K
$0.46
$11,500.00
455K
Dec 31
Form 4
+6.19%
25K
$1.29
$32,250.00
429K
Aug 23
Form 4
+32.89%
100K
$1.69
$169,000.00
404K
Mar 8
Form 4
—
0
—
—
0
Feb 9
Form 4
+3.41%
10K
$2.23
$22,300.00
303K
Sep 22
Form 4
+1.74%
5K
$1.85
$9,248.32
292K
Aug 22 - Aug 23
Form 4
+3.61%
10K
$1.61
$16,100.00
287K
Aug 15
Form 4
+9.92%
25K
$1.69
$42,250.00
277K
May 12
Form 4
—
0
—
—
0
Jan 31
Form 4
+11.06%
25K
$3.30
$82,500.00
251K
Dec 21
Form 4
+80.00%
100K
$2.39
$239,000.00
225K
Jun 24
Form 4
+0.20%
246
$3.20
$787.20
125K
May 25
Form 4
+4.84%
5.75K
$3.26
$18,758.04
124.75K
May 25
Form 4
+4.85%
5.5K
$3.37
$18,535.00
119K
May 24
Form 4
+7.08%
7.5K
$3.14
$23,580.00
113.5K
May 20 - May 23
Form 4
+6.00%
6K
$3.07
$18,420.00
106K
May 19
Form 4
—
0
—
—
0
Apr 1
Form 4
+29.42%
22.73K
$6.79
$154,434.40
100K
Nov 23 - Nov 24
Form 4
+47.83%
25K
$7.82
$195,500.00
77.27K
Aug 31
Form 4
+4.53%
2.27K
$7.08
$16,059.69
52.27K
Aug 27 - Aug 28
Form 4
∞
50K
$7.07
$353,300.00
50K
Aug 25 - Aug 26
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Dec 2
Form 3
—
0
—
—
0
No matching records found

Aquestive Therapeutics, Inc. (AQST) Snapshot price: $2.655

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Mar 11
Form 3
—
0
—
—
0
No matching records found

Forest Laboratories, LLC No price found

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-93.74K
—
—
0
Jul 1
Form 4
-3.12%
-3.02K
$92.23
-$278,165.68
93.74K
May 15
Form 4
-8.88%
-9.43K
$56.33
-$531,182.71
96.76K
Dec 6 - Dec 7
Form 4
-2.16%
-2.35K
$55.87
-$131,171.02
106.19K
Dec 5
Form 4
+17.19%
15.92K
—
—
108.54K
May 21
Form 4
-1.10%
-1.06K
$38.88
-$41,129.75
94.73K
May 15
Form 4
-7.42%
-7.51K
$35.78
-$268,743.58
93.67K
Dec 7 - Dec 8
Form 4
-3.89%
-4.09K
$35.83
-$146,524.25
101.19K
Dec 6
Form 4
-2.13%
-2.29K
$35.87
-$82,214.04
105.28K
Dec 5
Form 4
-10.78%
-13.00K
$35.51
-$461,630.50
107.57K
Sep 6
Form 4
+7.68%
8.6K
—
—
120.57K
May 7
Form 4
-3.01%
-3.48K
$29.87
-$103,857.99
111.97K
Dec 8
Form 4
-3.21%
-3.83K
$30.13
-$115,378.75
115.44K
Dec 7
Form 4
-3.76%
-4.66K
$30.08
-$140,135.93
119.28K
Dec 6
Form 4
+18.22%
19.1K
—
—
123.93K
Dec 5
Form 4
-2.78%
-3.00K
$34.72
-$104,164.50
104.83K
May 23
Form 4
-2.47%
-2.73K
$32.12
-$87,591.24
107.83K
Dec 8
Form 4
-3.18%
-3.64K
$32.20
-$117,061.02
110.56K
Dec 7
Form 4
+63.69%
44.43K
$32.17
-$18,301.88
114.2K
Dec 6
Form 4
-4.12%
-3.00K
$32.71
-$98,139.60
69.77K
Nov 18
Form 4
-3.81%
-2.88K
$30.77
-$88,740.68
72.77K
Dec 8
Form 4
+108.69%
39.4K
$31.45
-$18,898.44
75.65K
Dec 6 - Dec 7
Form 4
+480.00%
30K
—
—
36.25K
Dec 8
Form 4
∞
6.25K
—
—
6.25K
Dec 6
Form 4
—
0
—
—
0
Aug 13
Form 3
—
0
—
—
0
No matching records found

NephroGenex, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found